公司資料
Inovio Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- INO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
1.24 USD (0.00%)
收盤價
最後更新: 2026年9月21日
99.6M USD
市值
股價為何變動
截至 2026年9月21日，INO 股價變化不大，收於 $1.24。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Inovio Pharmaceuticals is a DNA-vaccine and immunotherapy company focused on infectious disease and oncology programs. Its business has long been tied to nucleic-acid delivery and immune activation.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Inovio sits in specialty biotechnology.
商業模式特徵
The company depends on clinical proof, platform validation, and the ability to turn DNA-based science into durable value.
生技產業定位
Inovio is a high-uncertainty platform biotech whose stock is sensitive to progress and credibility.
未來催化劑
- Inovio’s catalysts are INO-3107 and the rest of its DNA-vaccine platform, where the next clinical or regulatory update can either revive or weaken the story. Investors will care about whether the company can keep demonstrating that electroporation-based delivery still matters.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。